AA
BMY icon

Addison Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Addison Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$250K Buy
4,117
+99
+2% +$5.77K 0.06% 193
2025
Q4 		$217K Buy
4,018
+46
+1% +$2.21K 0.05% 209
2025
Q3 		$179K Buy
3,972
+232
+6% +$10.8K 0.04% 237
2025
Q2 		$173K Sell
3,740
-265
-7% -$13K 0.04% 238
2025
Q1 		$244K Buy
4,005
+28
+0.7% +$1.63K 0.07% 176
2024
Q4 		$225K Sell
3,977
-633
-14% -$35.4K 0.06% 186
2024
Q3 		$239K Buy
4,610
+312
+7% +$14.6K 0.07% 190
2024
Q2 		$178K Buy
4,298
+281
+7% +$12.6K 0.06% 215
2024
Q1 		$218K Buy
4,017
+166
+4% +$8.46K 0.07% 176
2023
Q4 		$198K Buy
3,851
+731
+23% +$38.4K 0.08% 178
2023
Q3 		$181K Buy
3,120
+192
+7% +$11.8K 0.08% 169
2023
Q2 		$187K Sell
2,928
-19
-0.6% -$1.27K 0.09% 158
2023
Q1 		$204K Buy
2,947
+20
+0.7% +$1.41K 0.11% 138
2022
Q4 		$211K Sell
2,927
-732
-20% -$55.2K 0.13% 125
2022
Q3 		$260K Buy
3,659
+74
+2% +$5.37K 0.16% 101
2022
Q2 		$276K Sell
3,585
-147
-4% -$11.2K 0.17% 100
2022
Q1 		$273K Buy
3,732
+548
+17% +$36.8K 0.15% 109
2021
Q4 		$199K Buy
3,184
+647
+26% +$38K 0.12% 119
2021
Q3 		$150K Buy
2,537
+12
+0.5% +$790 0.12% 100
2021
Q2 		$169K Buy
+2,525
New +$165K 0.14% 92
2020
Q4 		$164K Buy
+2,650
New +$163K 0.16% 90

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Addison Advisors's BMY Position: Q1 2026 in Review

Addison Advisors increased its Bristol-Myers Squibb (BMY) stake by 2.5% in Q1 2026, buying an estimated $5.77K and bringing the position to 4,117 shares worth $250K. The position accounts for 0.06% of the portfolio, ranked #193.

Addison Advisors first reported a position in BMY in Q4 2020 and has held it in 21 quarters since. The position peaked at $276K in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Addison Advisors held 4,117 shares of Bristol-Myers Squibb worth $250K as of Q1 2026.
  • Addison Advisors bought 99 Bristol-Myers Squibb shares in Q1 2026, an estimated $5.77K.
  • Bristol-Myers Squibb made up 0.06% of Addison Advisors's portfolio in Q1 2026, its #193 holding.
  • Addison Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 21 quarters since.
  • Addison Advisors's Bristol-Myers Squibb position peaked at $276K in Q2 2022.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Addison Advisors's 13F filing for Q1 2026, filed 8 May 2026.